Rajesh Shrotriya - Jul 15, 2022 Form 4 Insider Report for GT Biopharma, Inc. (GTBP)

Role
Director
Signature
/s/ Rajesh Shrotriya
Stock symbol
GTBP
Transactions as of
Jul 15, 2022
Transactions value $
$0
Form type
4
Date filed
7/19/2022, 09:46 PM
Previous filing
May 26, 2022
Next filing
Feb 1, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GTBP Option to purchase Common Stock Award $0 +50K $0.00 50K Jul 15, 2022 Common Stock 50K $2.48 Direct
transaction GTBP Option to purchase Common Stock Award $0 +50K $0.00 50K Jul 15, 2022 Common Stock 50K $2.48 Direct F1
transaction GTBP Option to purchase Common Stock Award $0 +361K $0.00 361K Jul 15, 2022 Common Stock 361K $2.48 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares vest on the date of grant and on each of September 8, 2022, December 8, 2022 and March 8, 2023.
F2 240,984 shares vest on the date of grant and 120,492 shares vest on January 13, 2023.